Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 18/20 | 0.57 |
| ▸ | ITGA2B | P08514 | 18/20 | 0.57 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.57 |
| ▸ | ITGAM | P11215 | 2/20 | 0.57 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | F10 | P00742 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9039117 | 0.88 | ITGB3 (0.43) | ITGB3ITGA2BITGB2ITGAM | |
| SCHEMBL9039133 | 0.86 | ITGB3 (0.43) | ITGB3ITGA2BITGB2ITGAM | |
| SCHEMBL7438736 | 0.83 | ITGB3 (0.53) | ITGB3ITGA2BITGB2ITGAM | |
| Hydrochloric Acid SCHEMBL7451925 | 0.82 | ITGB3 (0.52) | ITGB3ITGA2BITGB2ITGAM | |
| SCHEMBL9094515 | 0.81 | ITGB3 (0.48) | ITGB3ITGA2BITGB2ITGAMST14 | |
| SCHEMBL7444463 | 0.79 | ITGB3 (0.49) | ITGB3ITGA2B | |
| SCHEMBL7790925 | 0.79 | ITGB3 (0.39) | ITGB3ITGA2BF2F10 | |
| SCHEMBL7372378 | 0.79 | ITGB3 (0.39) | ITGB3ITGA2BF2F10 | |
| SCHEMBL8175498 | 0.78 | ITGB3 (0.56) | ITGB3ITGA2B | |
| SCHEMBL9093809 | 0.77 | ITGB3 (0.36) | ITGB3ITGA2BITGB2ITGAMF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995014682-A1 | ISOXAZOLINE COMPOUNDS USEFUL AS FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-06-01 | — | — | WO | disclosed |